No insider purchase over the last 90 days. The latest, by 王玉红, was filed 27 May 2025.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
11 of 11 declarations
Hubei Kailong Chemical Group Co., Ltd. (凯龙股份), a Chinese chemicals company listed in Shenzhen, has a record of 11 filings between July 2021 and May 2025 dominated by a single trade: a EUR 4,313,195 sale by 邵兴祥, 董事, on July 1, 2022. The same filer had bought EUR 120,178 on July 13, 2021, the first act in the record. In all, 6 sales represent EUR 4,632,254 (median EUR 74,841) and 5 purchases EUR 165,610 (median EUR 16,044), or 45% purchases.
李颂华, 高管, signs 3 filings, all sales, including EUR 119,972 on September 30, 2022 and EUR 102,183 on July 1, 2022. 邵峰, 董事 and 高管, has 2 purchases, including EUR 17,354 on January 29, 2024, and 王玉红, 监事, bought EUR 16,044 on May 27, 2025.
Yearly volume runs from 6 filings in 2022 to a single one in 2024 and in 2025. No filing falls in the last twelve months. Market capitalisation is CNY 3.8 billion, with 31.3% of the capital held by insiders.